Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - sodium acetate trihydrate 2,5 g/1026 ml - eq. sodium acetate 1,5 g/1026 ml; sodium glycerophosphate hydrate - eq. sodium glycerophosphate 1,48 mg/ml; glycine 2,3 mg/ml; glutamic acid 1,64 mg/ml; valine 2,14 mg/ml; arginine 3,31 mg/ml; lysine hydrochloride 3,31 mg/ml - eq. lysine 2,65 mg/ml; leucine 2,3 mg/ml; potassium chloride 1,75 mg/ml; serine 1,33 mg/ml; proline 1,99 mg/ml; alanine 4,68 mg/ml; histidine 1,99 mg/ml; threonine 1,64 mg/ml; tryptophan 0,55 mg/ml; soya oil 38,97 mg/ml; aspartic acid 1,01 mg/ml; glucose monohydrate 107,17 mg/ml - eq. glucose anhydrous 97,43 g/l; calcium chloride dihydrate 0,29 g/1026 ml - eq. calcium chloride 0,22 g/1026 ml; tyrosine 66,25 µg/ml; isoleucine 1,64 mg/ml; methionine 1,64 mg/ml; phenylalanine 2,3 mg/ml; magnesium sulfate 0,47 mg/ml - emulsion for infusion - glycine 2.3 mg/ml; glucose monohydrate 107.14 mg/ml; histidine 1.99 mg/ml; leucine 2.3 mg/ml; magnesium sulfate 0.47 mg/ml; isoleucine 1.64 mg/ml; lysine hydrochloride 3.31 mg/ml; methionine 1.64 mg/ml; phenylalanine 2.3 mg/ml; potassium chloride 1.75 mg/ml; proline 1.99 mg/ml; threonine 1.64 mg/ml; soya oil 38.97 mg/ml; tryptophan 0.55 mg/ml; sodium acetate trihydrate; tyrosine 66.25 µg/ml; sodium glycerophosphate hydrate; serine 1.33 mg/ml; aspartic acid 1.62 mg/ml; arginine 3.31 mg/ml; calcium chloride dihydrate; asparagine 1.01 mg/ml; alanine 4.68 mg/ml; valine 2.14 mg/ml - combinations

САЩ - английски - NLM (National Library of Medicine)

professional complementary health formulas - l-phenylalanine 4x, 7x, 12x - for the temporary relief of minor muscle or joint pain or inflammation, sadness, irritability, restlessness, or poor concentration.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

САЩ - английски - NLM (National Library of Medicine)

professional complementary health formulas - phenylalanine 9x, 12x, 30x, 60x - for the temporary relief of occasional headache, congestion, or lethargy due to sensitivity to phenolic compounds found in foods or other products.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - amoxicillin trihydrate 151.808 mg/ml equivalent to amoxycillin 120 mg/ml; potassium clavulanate 24.59 mg/ml (as potassium clavulanate/silicon dioxide 1:1 blend. equivalent to clavulanic acid 8.58mg/ml) - powder for oral suspension - 600mg/42.9mg per 5ml - active: amoxicillin trihydrate 151.808 mg/ml equivalent to amoxycillin 120 mg/ml potassium clavulanate 24.59 mg/ml (as potassium clavulanate/silicon dioxide 1:1 blend. equivalent to clavulanic acid 8.58mg/ml) excipient: aspartame carmellose sodium colloidal silicon dioxide silicon as silicon dioxide strawberry cream flavour 544428 xanthan gum

САЩ - английски - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), quercetin (unii: 9ikm0i5t1e) (quercetin - unii:9ikm0i5t1e), rutin (unii: 5g06tvy3r7) (rutin - unii:5g06tvy3r7), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), ferric chloride hexahydrate (unii: 0i2xin602u) (ferric cation - unii:91o4lml611), ferrosoferric phosphate (unii: 91gqh8i5f7) (ferrosoferric phosphate - unii:91gqh8i5f7), ferrous sulfate (unii: 39r4tan1vt) ( - phenylalanine 6 [hp_x] in 1 ml - temporary relief of symptoms related to iron in foods and supplements, including fatigue, cramping and jitteriness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to iron in foods and supplements, including fatigue, cramping and jitteriness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

САЩ - английски - NLM (National Library of Medicine)

deseret biologicals, inc. - phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), taurine (unii: 1eqv5mly3d) (taurine - unii:1eqv5mly3d), sus scrofa nerve (unii: jxv50i6zhk) (sus scrofa nerve - unii:jxv50i6zhk), adenosine triphosphate disodium (unii: 5l51b4dr1g) (adenosine triphosphate - unii:8l70q75fxe), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sus scrofa cerebrum (unii: 4gb5dqr532) (sus scrofa cerebrum - unii:4gb5dqr532), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9f - phenylalanine 6 [hp_x] in 1 ml - temporary relief of symptoms related to blocked energy in the body including fatigue, temperature fluctuations, cramping and nervousness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. temporary relief of symptoms related to blocked energy in the body including fatigue, temperature fluctuations, cramping and nervousness.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - cysteine hydrochloride 0,42 mg/ml; histidine 5,1 mg/ml; glycine 5,9 mg/ml; glutamic acid 4,2 mg/ml; isoleucine 4,2 mg/ml; magnesium sulfate 1,97 mg/ml; lysine hydrochloride - eq. lysine 6,8 mg/ml; methionine 4,2 mg/ml; leucine 5,9 mg/ml; phenylalanine 5,9 mg/ml; potassium chloride 3,73 mg/ml; proline 5,1 mg/ml; sodium acetate trihydrate - eq. sodium acetate 13,6 mg/ml; tryptophan 1,4 mg/ml; threonine 4,2 mg/ml; tyrosine 0,17 mg/ml; serine 3,4 mg/ml; alanine 12 mg/ml; aspartic acid 2,5 mg/ml; arginine 8,4 mg/ml; calcium gluconate 2,24 mg/ml; valine 5,5 mg/ml - solution for infusion - cysteine hydrochloride 0.42 mg/ml; histidine 5.1 mg/ml; glycine 5.9 mg/ml; glutamic acid 4.2 mg/ml; isoleucine 4.2 mg/ml; magnesium sulfate 1.97 mg/ml; lysine hydrochloride; methionine 4.2 mg/ml; leucine 5.9 mg/ml; phenylalanine 5.9 mg/ml; potassium chloride 3.73 mg/ml; proline 5.1 mg/ml; sodium acetate trihydrate; tryptophan 1.4 mg/ml; threonine 4.2 mg/ml; tyrosine 0.17 mg/ml; serine 3.4 mg/ml; alanine 12 mg/ml; aspartic acid 2.5 mg/ml; arginine 8.4 mg/ml; calcium gluconate 2.24 mg/ml; valine 5.5 mg/ml - combinations

Белгия - английски - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - cysteine hydrochloride 0,42 mg/ml; histidine 5,1 mg/ml; glycine 5,9 mg/ml; glutamic acid 4,2 mg/ml; isoleucine 4,2 mg/ml; magnesium sulfate 1,97 mg/ml; lysine hydrochloride - eq. lysine 6,8 mg/ml; methionine 4,2 mg/ml; leucine 5,9 mg/ml; phenylalanine 5,9 mg/ml; potassium chloride 3,73 mg/ml; proline 5,1 mg/ml; sodium acetate trihydrate - eq. sodium acetate 13,6 mg/ml; tryptophan 1,4 mg/ml; threonine 4,2 mg/ml; tyrosine 0,17 mg/ml; serine 3,4 mg/ml; alanine 12 mg/ml; aspartic acid 2,5 mg/ml; arginine 8,4 mg/ml; calcium gluconate 2,24 mg/ml; valine 5,5 mg/ml - solution for infusion - cysteine hydrochloride 0.42 mg/ml; glycine 5.9 mg/ml; histidine 5.1 mg/ml; glutamic acid 4.2 mg/ml; magnesium sulfate 1.97 mg/ml; lysine hydrochloride; methionine 4.2 mg/ml; isoleucine 4.2 mg/ml; leucine 5.9 mg/ml; potassium chloride 3.73 mg/ml; phenylalanine 5.9 mg/ml; proline 5.1 mg/ml; tyrosine 0.17 mg/ml; threonine 4.2 mg/ml; sodium acetate trihydrate; serine 3.4 mg/ml; tryptophan 1.4 mg/ml; alanine 12 mg/ml; aspartic acid 2.5 mg/ml; arginine 8.4 mg/ml; calcium gluconate 2.24 mg/ml; valine 5.5 mg/ml - combinations

Малта - английски - Medicines Authority

villerton invest s.a. rue edward steichen 14, 2540, luxembourg - fluconazole - solution for infusion - fluconazole 2 mg/ml - antimycotics for systemic use

Австралия - английски - Department of Health (Therapeutic Goods Administration)

recordati rare diseases australia pty ltd - dinutuximab beta, quantity: 4.5 mg/ml - solution - excipient ingredients: polysorbate 20; hydrochloric acid; sucrose; water for injections; histidine - qarziba is indicated for the treatment of high-risk neuroblastoma in patients who have previously received induction chemotherapy and achieved at least a partial response.